Global Cancer Pain Market Growth 2020-2025
According to this study, over the next five years the Cancer Pain market will register a xx%% CAGR in terms of revenue, the global market size will reach $ xx million by 2025, from $ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Cancer Pain business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Cancer Pain market by product type, application, key manufacturers and key regions and countries.
This study specially analyses the impact of Covid-19 outbreak on the Cancer Pain, covering the supply chain analysis, impact assessment to the Cancer Pain market size growth rate in several scenarios, and the measures to be undertaken by Cancer Pain companies in response to the COVID-19 epidemic.
Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.
Opioids
Non-Steroidal Anti-Inflammatory Drugs
Others
Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.
Radiotherapy
Chemotherapy
Hormone Therapy
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
BioDelivery Science
Sanofi
ProStrakan Group
Eli-Lilly
Grunenthal Group
Teva pharmaceuticals
Meda Pharmaceuticals
GW Pharmaceuticals
Orexo
Johnson＆Johnson
WEX Pharmaceuticals
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Cancer Pain consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.
To understand the structure of Cancer Pain market by identifying its various subsegments.
Focuses on the key global Cancer Pain manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Cancer Pain with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Cancer Pain submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Cancer Pain Consumption 2015-2025
2.1.2 Cancer Pain Consumption CAGR by Region
2.2 Cancer Pain Segment by Type
2.2.1 Opioids
2.2.2 Non-Steroidal Anti-Inflammatory Drugs
2.2.3 Others
2.3 Cancer Pain Consumption by Type
2.3.1 Global Cancer Pain Consumption Market Share by Type (2015-2020)
2.3.2 Global Cancer Pain Revenue and Market Share by Type (2015-2020)
2.3.3 Global Cancer Pain Sale Price by Type (2015-2020)
2.4 Cancer Pain Segment by Application
2.4.1 Radiotherapy
2.4.2 Chemotherapy
2.4.3 Hormone Therapy
2.4.4 Others
2.5 Cancer Pain Consumption by Application
2.5.1 Global Cancer Pain Consumption Market Share by Type (2015-2020)
2.5.2 Global Cancer Pain Value and Market Share by Type (2015-2020)
2.5.3 Global Cancer Pain Sale Price by Type (2015-2020)
3 Global Cancer Pain by Company
3.1 Global Cancer Pain Sales Market Share by Company
3.1.1 Global Cancer Pain Sales by Company (2018-2020)
3.1.2 Global Cancer Pain Sales Market Share by Company (2018-2020)
3.2 Global Cancer Pain Revenue Market Share by Company
3.2.1 Global Cancer Pain Revenue by Company (2018-2020)
3.2.2 Global Cancer Pain Revenue Market Share by Company (2018-2020)
3.3 Global Cancer Pain Sale Price by Company
3.4 Global Cancer Pain Manufacturing Base Distribution, Sales Area, Type by Company
3.4.1 Global Cancer Pain Manufacturing Base Distribution and Sales Area by Company
3.4.2 Players Cancer Pain Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Cancer Pain by Regions
4.1 Cancer Pain by Regions
4.2 Americas Cancer Pain Consumption Growth
4.3 APAC Cancer Pain Consumption Growth
4.4 Europe Cancer Pain Consumption Growth
4.5 Middle East & Africa Cancer Pain Consumption Growth
5 Americas
5.1 Americas Cancer Pain Consumption by Countries
5.1.1 Americas Cancer Pain Consumption by Countries (2015-2020)
5.1.2 Americas Cancer Pain Value by Countries (2015-2020)
5.2 Americas Cancer Pain Consumption by Type
5.3 Americas Cancer Pain Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
5.8 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Cancer Pain Consumption by Regions
6.1.1 APAC Cancer Pain Consumption by Regions (2015-2020)
6.1.2 APAC Cancer Pain Value by Regions (2015-2020)
6.2 APAC Cancer Pain Consumption by Type
6.3 APAC Cancer Pain Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions
7 Europe
7.1 Europe Cancer Pain by Countries
7.1.1 Europe Cancer Pain Consumption by Countries (2015-2020)
7.1.2 Europe Cancer Pain Value by Countries (2015-2020)
7.2 Europe Cancer Pain Consumption by Type
7.3 Europe Cancer Pain Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa Cancer Pain by Countries
8.1.1 Middle East & Africa Cancer Pain Consumption by Countries (2015-2020)
8.1.2 Middle East & Africa Cancer Pain Value by Countries (2015-2020)
8.2 Middle East & Africa Cancer Pain Consumption by Type
8.3 Middle East & Africa Cancer Pain Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Cancer Pain Distributors
10.3 Cancer Pain Customer
11 Global Cancer Pain Market Forecast
11.1 Global Cancer Pain Consumption Forecast (2021-2025)
11.2 Global Cancer Pain Forecast by Regions
11.2.1 Global Cancer Pain Forecast by Regions (2021-2025)
11.2.2 Global Cancer Pain Value Forecast by Regions (2021-2025)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast byRegions
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Cancer Pain Forecast by Type
11.8 Global Cancer Pain Forecast by Application
12 Key Players Analysis
12.1 BioDelivery Science
12.1.1 Company Information
12.1.2 Cancer Pain Product Offered
12.1.3 BioDelivery Science Cancer Pain Sales, Revenue, Price and Gross Margin (2018-2020)
12.1.4 Main Business Overview
12.1.5 BioDelivery Science Latest Developments
12.2 Sanofi
12.2.1 Company Information
12.2.2 Cancer Pain Product Offered
12.2.3 Sanofi Cancer Pain Sales, Revenue, Price and Gross Margin (2018-2020)
12.2.4 Main Business Overview
12.2.5 Sanofi Latest Developments
12.3 ProStrakan Group
12.3.1 Company Information
12.3.2 Cancer Pain Product Offered
12.3.3 ProStrakan Group Cancer Pain Sales, Revenue, Price and Gross Margin (2018-2020)
12.3.4 Main Business Overview
12.3.5 ProStrakan Group Latest Developments
12.4 Eli-Lilly
12.4.1 Company Information
12.4.2 Cancer Pain Product Offered
12.4.3 Eli-Lilly Cancer Pain Sales, Revenue, Price and Gross Margin (2018-2020)
12.4.4 Main Business Overview
12.4.5 Eli-Lilly Latest Developments
12.5 Grunenthal Group
12.5.1 Company Information
12.5.2 Cancer Pain Product Offered
12.5.3 Grunenthal Group Cancer Pain Sales, Revenue, Price and Gross Margin (2018-2020)
12.5.4 Main Business Overview
12.5.5 Grunenthal Group Latest Developments
12.6 Teva pharmaceuticals
12.6.1 Company Information
12.6.2 Cancer Pain Product Offered
12.6.3 Teva pharmaceuticals Cancer Pain Sales, Revenue, Price and Gross Margin (2018-2020)
12.6.4 Main Business Overview
12.6.5 Teva pharmaceuticals Latest Developments
12.7 Meda Pharmaceuticals
12.7.1 Company Information
12.7.2 Cancer Pain Product Offered
12.7.3 Meda Pharmaceuticals Cancer Pain Sales, Revenue, Price and Gross Margin (2018-2020)
12.7.4 Main Business Overview
12.7.5 Meda Pharmaceuticals Latest Developments
12.8 GW Pharmaceuticals
12.8.1 Company Information
12.8.2 Cancer Pain Product Offered
12.8.3 GW Pharmaceuticals Cancer Pain Sales, Revenue, Price and Gross Margin (2018-2020)
12.8.4 Main Business Overview
12.8.5 GW Pharmaceuticals Latest Developments
12.9 Orexo
12.9.1 Company Information
12.9.2 Cancer Pain Product Offered
12.9.3 Orexo Cancer Pain Sales, Revenue, Price and Gross Margin (2018-2020)
12.9.4 Main Business Overview
12.9.5 Orexo Latest Developments
12.10 Johnson＆Johnson
12.10.1 Company Information
12.10.2 Cancer Pain Product Offered
12.10.3 Johnson＆Johnson Cancer Pain Sales, Revenue, Price and Gross Margin (2018-2020)
12.10.4 Main Business Overview
12.10.5 Johnson＆Johnson Latest Developments
12.11 WEX Pharmaceuticals
12.11.1 Company Information
12.11.2 Cancer Pain Product Offered
12.11.3 WEX Pharmaceuticals Cancer Pain Sales, Revenue, Price and Gross Margin (2018-2020)
12.11.4 Main Business Overview
12.11.5 WEX Pharmaceuticals Latest Developments
13 Research Findings and Conclusion
Tables and Figures
List of Tables
Table 1. Research Methodology
Table 2. Data Source
Table 3. Cancer Pain Consumption CAGR by Region 2015-2025 ($ Millions)
Table 4. Major Players of Opioids
Table 5. Major Players of Non-Steroidal Anti-Inflammatory Drugs
Table 6. Major Players of Others
Table 7. Global Consumption Sales by Type (2015-2020)
Table 8. Global Cancer Pain Consumption Market Share by Type (2015-2020)
Table 9. Global Cancer Pain Revenue by Type (2015-2020) ($ million)
Table 10. Global Cancer Pain Value Market Share by Type (2015-2020) ($ Millions)
Table 11. Global Cancer Pain Sale Price by Type (2015-2020)
Table 12. Global Consumption Sales by Application (2015-2020)
Table 13. Global Cancer Pain Consumption Market Share by Application (2015-2020)
Table 14. Global Cancer Pain Value by Application (2015-2020)
Table 15. Global Cancer Pain Value Market Share by Application (2015-2020)
Table 16. Global Cancer Pain Sale Price by Application (2015-2020)
Table 17. Global Cancer Pain Sales by Company (2017-2019) (K Units)
Table 18. Global Cancer Pain Sales Market Share by Company (2017-2019)
Table 19. Global Cancer Pain Revenue by Company (2017-2019) ($ Millions)
Table 20. Global Cancer Pain Revenue Market Share by Company (2017-2019)
Table 21. Global Cancer Pain Sale Price by Company (2017-2019)
Table 22. Global Cancer Pain Manufacturing Base Distribution and Sales Area by Manufacturers
Table 23. Players Cancer Pain Products Offered
Table 24. Cancer Pain Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
Table 25. Global Cancer Pain Consumption by Regions 2015-2020 (K Units)
Table 26. Global Cancer Pain Consumption Market Share by Regions 2015-2020
Table 27. Global Cancer Pain Value by Regions 2015-2020 ($ Millions)
Table 28. Global Cancer Pain Value Market Share by Regions 2015-2020
Table 29. Americas Cancer Pain Consumption by Countries (2015-2020) (K Units)
Table 30. Americas Cancer Pain Consumption Market Share by Countries (2015-2020)
Table 31. Americas Cancer Pain Value by Countries (2015-2020) ($ Millions)
Table 32. Americas Cancer Pain Value Market Share by Countries (2015-2020)
Table 33. Americas Cancer Pain Consumption by Type (2015-2020) (K Units)
Table 34. Americas Cancer Pain Consumption Market Share by Type (2015-2020)
Table 35. Americas Cancer Pain Consumption by Application (2015-2020) (K Units)
Table 36. Americas Cancer Pain Consumption Market Share by Application (2015-2020)
Table 37. APAC Cancer Pain Consumption by Regions (2015-2020) (K Units)
Table 38. APAC Cancer Pain Consumption Market Share by Regions (2015-2020)
Table 39. APAC Cancer Pain Value by Regions (2015-2020) ($ Millions)
Table 40. APAC Cancer Pain Value Market Share by Regions (2015-2020)
Table 41. APAC Cancer Pain Consumption by Type (2015-2020) (K Units)
Table 42. APAC Cancer Pain Consumption Market Share by Type (2015-2020)
Table 43. APAC Cancer Pain Consumption by Application (2015-2020) (K Units)
Table 44. APAC Cancer Pain Consumption Market Share by Application (2015-2020)
Table 45. Europe Cancer Pain Consumption by Countries (2015-2020) (K Units)
Table 46. Europe Cancer Pain Consumption Market Share by Countries (2015-2020)
Table 47. Europe Cancer Pain Value by Countries (2015-2020) ($ Millions)
Table 48. Europe Cancer Pain Value Market Share by Countries (2015-2020)
Table 49. Europe Cancer Pain Consumption by Type (2015-2020) (K Units)
Table 50. Europe Cancer Pain Consumption Market Share by Type (2015-2020)
Table 51. Europe Cancer Pain Consumption by Application (2015-2020) (K Units)
Table 52. Europe Cancer Pain Consumption Market Share by Application (2015-2020)
Table 53. Middle East & Africa Cancer Pain Consumption by Countries (2015-2020) (K Units)
Table 54. Middle East & Africa Cancer Pain Consumption Market Share by Countries (2015-2020)
Table 55. Middle East & Africa Cancer Pain Value by Countries (2015-2020) ($ Millions)
Table 56. Middle East & Africa Cancer Pain Value Market Share by Countries (2015-2020)
Table 57. Middle East & Africa Cancer Pain Consumption by Type (2015-2020) (K Units)
Table 58. Middle East & Africa Cancer Pain Consumption Market Share by Type (2015-2020)
Table 59. Middle East & Africa Cancer Pain Consumption by Application (2015-2020) (K Units)
Table 60. Middle East & Africa Cancer Pain Consumption Market Share by Application (2015-2020)
Table 61. Cancer Pain Distributors List
Table 62. Cancer Pain Customer List
Table 63. Global Cancer Pain Consumption Forecast by Countries (2021-2025) (K Units)
Table 64. Global Cancer Pain Consumption Market Forecast by Regions
Table 65. Global Cancer Pain Value Forecast by Countries (2021-2025) ($ Millions)
Table 66. Global Cancer Pain Value Market Share Forecast by Regions
Table 67. Global Cancer Pain Consumption Forecast by Type (2021-2025) (K Units)
Table 68. Global Cancer Pain Consumption Market Share Forecast by Type (2021-2025)
Table 69. Global Cancer Pain Value Forecast by Type (2021-2025) ($ Millions)
Table 70. Global Cancer Pain Value Market Share Forecast by Type (2021-2025)
Table 71. Global Cancer Pain Consumption Forecast by Application (2021-2025) (K Units)
Table 72. Global Cancer Pain Consumption Market Share Forecast by Application (2021-2025)
Table 73. Global Cancer Pain Value Forecast by Application (2021-2025) ($ Millions)
Table 74. Global Cancer Pain Value Market Share Forecast by Application (2021-2025)
Table 75. BioDelivery Science Product Offered
Table 76. BioDelivery Science Cancer Pain Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 77. BioDelivery Science Main Business
Table 78. BioDelivery Science Latest Developments
Table 79. BioDelivery Science Basic Information, Company Total Revenue (in $ million), Cancer Pain Manufacturing Base, Sales Area and Its Competitors
Table 80. Sanofi Product Offered
Table 81. Sanofi Cancer Pain Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 82. Sanofi Main Business
Table 83. Sanofi Latest Developments
Table 84. Sanofi Basic Information, Company Total Revenue (in $ million), Cancer Pain Manufacturing Base, Sales Area and Its Competitors
Table 85. ProStrakan Group Product Offered
Table 86. ProStrakan Group Cancer Pain Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 87. ProStrakan Group Main Business
Table 88. ProStrakan Group Latest Developments
Table 89. ProStrakan Group Basic Information, Company Total Revenue (in $ million), Cancer Pain Manufacturing Base, Sales Area and Its Competitors
Table 90. Eli-Lilly Product Offered
Table 91. Eli-Lilly Cancer Pain Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 92. Eli-Lilly Main Business
Table 93. Eli-Lilly Latest Developments
Table 94. Eli-Lilly Basic Information, Company Total Revenue (in $ million), Cancer Pain Manufacturing Base, Sales Area and Its Competitors
Table 95. Grunenthal Group Product Offered
Table 96. Grunenthal Group Cancer Pain Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 97. Grunenthal Group Main Business
Table 98. Grunenthal Group Latest Developments
Table 99. Grunenthal Group Basic Information, Company Total Revenue (in $ million), Cancer Pain Manufacturing Base, Sales Area and Its Competitors
Table 100. Teva pharmaceuticals Product Offered
Table 101. Teva pharmaceuticals Cancer Pain Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 102. Teva pharmaceuticals Main Business
Table 103. Teva pharmaceuticals Latest Developments
Table 104. Teva pharmaceuticals Basic Information, Company Total Revenue (in $ million), Cancer Pain Manufacturing Base, Sales Area and Its Competitors
Table 105. Meda Pharmaceuticals Product Offered
Table 106. Meda Pharmaceuticals Basic Information, Company Total Revenue (in $ million), Cancer Pain Manufacturing Base, Sales Area and Its Competitors
Table 107. Meda Pharmaceuticals Main Business
Table 108. Meda Pharmaceuticals Latest Developments
Table 109. Meda Pharmaceuticals Cancer Pain Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 110. GW Pharmaceuticals Product Offered
Table 111. GW Pharmaceuticals Cancer Pain Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 112. GW Pharmaceuticals Main Business
Table 113. GW Pharmaceuticals Latest Developments
Table 114. GW Pharmaceuticals Basic Information, Company Total Revenue (in $ million), Cancer Pain Manufacturing Base, Sales Area and Its Competitors
Table 115. Orexo Product Offered
Table 116. Orexo Cancer Pain Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 117. Orexo Main Business
Table 118. Orexo Latest Developments
Table 119. Orexo Basic Information, Company Total Revenue (in $ million), Cancer Pain Manufacturing Base, Sales Area and Its Competitors
Table 120. Johnson＆Johnson Product Offered
Table 121. Johnson＆Johnson Cancer Pain Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 122. Johnson＆Johnson Main Business
Table 123. Johnson＆Johnson Latest Developments
Table 124. Johnson＆Johnson Basic Information, Company Total Revenue (in $ million), Cancer Pain Manufacturing Base, Sales Area and Its Competitors
Table 125. WEX Pharmaceuticals Product Offered
Table 126. WEX Pharmaceuticals Cancer Pain Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 127. WEX Pharmaceuticals Main Business
Table 128. WEX Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 129. WEX Pharmaceuticals Latest Developments
List of Figures
Figure 1. Picture of Cancer Pain
Figure 2. Cancer Pain Report Years Considered
Figure 3. Market Research Methodology
Figure 4. Global Cancer Pain Consumption Growth Rate 2015-2025 (K Units)
Figure 5. Global Cancer Pain Value Growth Rate 2015-2025 ($ Millions)
Figure 6. Product Picture of Opioids
Figure 7. Product Picture of Non-Steroidal Anti-Inflammatory Drugs
Figure 8. Product Picture of Others
Figure 9. Global Cancer Pain Consumption Market Share by Type (2015-2020)
Figure 10. Global Cancer Pain Value Market Share by Type (2015-2020)
Figure 11. Cancer Pain Consumed in Radiotherapy
Figure 12. Global Cancer Pain Market: Radiotherapy (2015-2020) (K Units)
Figure 13. Global Cancer Pain Market: Radiotherapy (2015-2020) ($ Millions)
Figure 14. Cancer Pain Consumed in Chemotherapy
Figure 15. Global Cancer Pain Market: Chemotherapy (2015-2020) (K Units)
Figure 16. Global Cancer Pain Market: Chemotherapy (2015-2020) ($ Millions)
Figure 17. Cancer Pain Consumed in Hormone Therapy
Figure 18. Global Cancer Pain Market: Hormone Therapy (2015-2020) (K Units)
Figure 19. Global Cancer Pain Market: Hormone Therapy (2015-2020) ($ Millions)
Figure 20. Cancer Pain Consumed in Others
Figure 21. Global Cancer Pain Market: Others (2015-2020) (K Units)
Figure 22. Global Cancer Pain Market: Others (2015-2020) ($ Millions)
Figure 23. Global Cancer Pain Consumption Market Share by Application (2015-2020)
Figure 24. Global Cancer Pain Value Market Share by Application (2015-2020)
Figure 25. Global Cancer Pain Sales Market Share by Company in 2017
Figure 26. Global Cancer Pain Sales Market Share by Company in 2019
Figure 27. Global Cancer Pain Revenue Market Share by Company in 2017
Figure 28. Global Cancer Pain Revenue Market Share by Company in 2019
Figure 29. Global Cancer Pain Sale Price by Company in 2019
Figure 30. Global Cancer Pain Consumption Market Share by Regions 2015-2020
Figure 31. Global Cancer Pain Value Market Share by Regions 2015-2020
Figure 32. Americas Cancer Pain Consumption 2015-2020 (K Units)
Figure 33. Americas Cancer Pain Value 2015-2020 ($ Millions)
Figure 34. APAC Cancer Pain Consumption 2015-2020 (K Units)
Figure 35. APAC Cancer Pain Value 2015-2020 ($ Millions)
Figure 36. Europe Cancer Pain Consumption 2015-2020 (K Units)
Figure 37. Europe Cancer Pain Value 2015-2020 ($ Millions)
Figure 38. Middle East & Africa Cancer Pain Consumption 2015-2020 (K Units)
Figure 39. Middle East & Africa Cancer Pain Value 2015-2020 ($ Millions)
Figure 40. Americas Cancer Pain Consumption Market Share by Countries in 2019
Figure 41. Americas Cancer Pain Value Market Share by Countries in 2019
Figure 42. Americas Cancer Pain Consumption Market Share by Type in 2019
Figure 43. Americas Cancer Pain Consumption Market Share by Application in 2019
Figure 44. United States Cancer Pain Consumption Growth 2015-2020 (K Units)
Figure 45. United States Cancer Pain Value Growth 2015-2020 ($ Millions)
Figure 46. Canada Cancer Pain Consumption Growth 2015-2020 (K Units)
Figure 47. Canada Cancer Pain Value Growth 2015-2020 ($ Millions)
Figure 48. Mexico Cancer Pain Consumption Growth 2015-2020 (K Units)
Figure 49. Mexico Cancer Pain Value Growth 2015-2020 ($ Millions)
Figure 50. APAC Cancer Pain Consumption Market Share by Countries in 2019
Figure 51. APAC Cancer Pain Value Market Share by Regions in 2019
Figure 52. APAC Cancer Pain Consumption Market Share by Type in 2019
Figure 53. APAC Cancer Pain Consumption Market Share by Application in 2019
Figure 54. China Cancer Pain Consumption Growth 2015-2020 (K Units)
Figure 55. China Cancer Pain Value Growth 2015-2020 ($ Millions)
Figure 56. Japan Cancer Pain Consumption Growth 2015-2020 (K Units)
Figure 57. Japan Cancer Pain Value Growth 2015-2020 ($ Millions)
Figure 58. Korea Cancer Pain Consumption Growth 2015-2020 (K Units)
Figure 59. Korea Cancer Pain Value Growth 2015-2020 ($ Millions)
Figure 60. Southeast Asia Cancer Pain Consumption Growth 2015-2020 (K Units)
Figure 61. Southeast Asia Cancer Pain Value Growth 2015-2020 ($ Millions)
Figure 62. India Cancer Pain Consumption Growth 2015-2020 (K Units)
Figure 63. India Cancer Pain Value Growth 2015-2020 ($ Millions)
Figure 64. Australia Cancer Pain Consumption Growth 2015-2020 (K Units)
Figure 65. Australia Cancer Pain Value Growth 2015-2020 ($ Millions)
Figure 66. Europe Cancer Pain Consumption Market Share by Countries in 2019
Figure 67. Europe Cancer Pain Value Market Share by Countries in 2019
Figure 68. Europe Cancer Pain Consumption Market Share by Type in 2019
Figure 69. Europe Cancer Pain Consumption Market Share by Application in 2019
Figure 70. Germany Cancer Pain Consumption Growth 2015-2020 (K Units)
Figure 71. Germany Cancer Pain Value Growth 2015-2020 ($ Millions)
Figure 72. France Cancer Pain Consumption Growth 2015-2020 (K Units)
Figure 73. France Cancer Pain Value Growth 2015-2020 ($ Millions)
Figure 74. UK Cancer Pain Consumption Growth 2015-2020 (K Units)
Figure 75. UK Cancer Pain Value Growth 2015-2020 ($ Millions)
Figure 76. Italy Cancer Pain Consumption Growth 2015-2020 (K Units)
Figure 77. Italy Cancer Pain Value Growth 2015-2020 ($ Millions)
Figure 78. Russia Cancer Pain Consumption Growth 2015-2020 (K Units)
Figure 79. Russia Cancer Pain Value Growth 2015-2020 ($ Millions)
Figure 80. Middle East & Africa Cancer Pain Consumption Market Share by Countries in 2019
Figure 81. Middle East & Africa Cancer Pain Value Market Share by Countries in 2019
Figure 82. Middle East & Africa Cancer Pain Consumption Market Share by Type in 2019
Figure 83. Middle East & Africa Cancer Pain Consumption Market Share by Application in 2019
Figure 84. Egypt Cancer Pain Consumption Growth 2015-2020 (K Units)
Figure 85. Egypt Cancer Pain Value Growth 2015-2020 ($ Millions)
Figure 86. South Africa Cancer Pain Consumption Growth 2015-2020 (K Units)
Figure 87. South Africa Cancer Pain Value Growth 2015-2020 ($ Millions)
Figure 88. Israel Cancer Pain Consumption Growth 2015-2020 (K Units)
Figure 89. Israel Cancer Pain Value Growth 2015-2020 ($ Millions)
Figure 90. Turkey Cancer Pain Consumption Growth 2015-2020 (K Units)
Figure 91. Turkey Cancer Pain Value Growth 2015-2020 ($ Millions)
Figure 92. GCC Countries Cancer Pain Consumption Growth 2015-2020 (K Units)
Figure 93. GCC Countries Cancer Pain Value Growth 2015-2020 ($ Millions)
Figure 94. Global Cancer Pain Consumption Growth Rate Forecast (2021-2025) (K Units)
Figure 95. Global Cancer Pain Value Growth Rate Forecast (2021-2025) ($ Millions)
Figure 96. Americas Cancer Pain Consumption 2021-2025 (K Units)
Figure 97. Americas Cancer Pain Value 2021-2025 ($ Millions)
Figure 98. APAC Cancer Pain Consumption 2021-2025 (K Units)
Figure 99. APAC Cancer Pain Value 2021-2025 ($ Millions)
Figure 100. Europe Cancer Pain Consumption 2021-2025 (K Units)
Figure 101. Europe Cancer Pain Value 2021-2025 ($ Millions)
Figure 102. Middle East & Africa Cancer Pain Consumption 2021-2025 (K Units)
Figure 103. Middle East & Africa Cancer Pain Value 2021-2025 ($ Millions)
Figure 104. United States Cancer Pain Consumption 2021-2025 (K Units)
Figure 105. United States Cancer Pain Value 2021-2025 ($ Millions)
Figure 106. Canada Cancer Pain Consumption 2021-2025 (K Units)
Figure 107. Canada Cancer Pain Value 2021-2025 ($ Millions)
Figure 108. Mexico Cancer Pain Consumption 2021-2025 (K Units)
Figure 109. Mexico Cancer Pain Value 2021-2025 ($ Millions)
Figure 110. Brazil Cancer Pain Consumption 2021-2025 (K Units)
Figure 111. Brazil Cancer Pain Value 2021-2025 ($ Millions)
Figure 112. China Cancer Pain Consumption 2021-2025 (K Units)
Figure 113. China Cancer Pain Value 2021-2025 ($ Millions)
Figure 114. Japan Cancer Pain Consumption 2021-2025 (K Units)
Figure 115. Japan Cancer Pain Value 2021-2025 ($ Millions)
Figure 116. Korea Cancer Pain Consumption 2021-2025 (K Units)
Figure 117. Korea Cancer Pain Value 2021-2025 ($ Millions)
Figure 118. Southeast Asia Cancer Pain Consumption 2021-2025 (K Units)
Figure 119. Southeast Asia Cancer Pain Value 2021-2025 ($ Millions)
Figure 120. India Cancer Pain Consumption 2021-2025 (K Units)
Figure 121. India Cancer Pain Value 2021-2025 ($ Millions)
Figure 122. Australia Cancer Pain Consumption 2021-2025 (K Units)
Figure 123. Australia Cancer Pain Value 2021-2025 ($ Millions)
Figure 124. Germany Cancer Pain Consumption 2021-2025 (K Units)
Figure 125. Germany Cancer Pain Value 2021-2025 ($ Millions)
Figure 126. France Cancer Pain Consumption 2021-2025 (K Units)
Figure 127. France Cancer Pain Value 2021-2025 ($ Millions)
Figure 128. UK Cancer Pain Consumption 2021-2025 (K Units)
Figure 129. UK Cancer Pain Value 2021-2025 ($ Millions)
Figure 130. Italy Cancer Pain Consumption 2021-2025 (K Units)
Figure 131. Italy Cancer Pain Value 2021-2025 ($ Millions)
Figure 132. Russia Cancer Pain Consumption 2021-2025 (K Units)
Figure 133. Russia Cancer Pain Value 2021-2025 ($ Millions)
Figure 134. Spain Cancer Pain Consumption 2021-2025 (K Units)
Figure 135. Spain Cancer Pain Value 2021-2025 ($ Millions)
Figure 136. Egypt Cancer Pain Consumption 2021-2025 (K Units)
Figure 137. Egypt Cancer Pain Value 2021-2025 ($ Millions)
Figure 138. South Africa Cancer Pain Consumption 2021-2025 (K Units)
Figure 139. South Africa Cancer Pain Value 2021-2025 ($ Millions)
Figure 140. Israel Cancer Pain Consumption 2021-2025 (K Units)
Figure 141. Israel Cancer Pain Value 2021-2025 ($ Millions)
Figure 142. Turkey Cancer Pain Consumption 2021-2025 (K Units)
Figure 143. Turkey Cancer Pain Value 2021-2025 ($ Millions)
Figure 144. GCC Countries Cancer Pain Consumption 2021-2025 (K Units)
Figure 145. GCC Countries Cancer Pain Value 2021-2025 ($ Millions)
Figure 146. BioDelivery Science Cancer Pain Market Share (2018-2020)
Figure 147. Sanofi Cancer Pain Market Share (2018-2020)
Figure 148. ProStrakan Group Cancer Pain Market Share (2018-2020)
Figure 149. Eli-Lilly Cancer Pain Market Share (2018-2020)
Figure 150. Grunenthal Group Cancer Pain Market Share (2018-2020)
Figure 151. Teva pharmaceuticals Cancer Pain Market Share (2018-2020)
Figure 152. Meda Pharmaceuticals Cancer Pain Market Share (2018-2020)
Figure 153. GW Pharmaceuticals Cancer Pain Market Share (2018-2020)
Figure 154. Orexo Cancer Pain Market Share (2018-2020)
Figure 155. Johnson＆Johnson Cancer Pain Market Share (2018-2020)
Figure 156. WEX Pharmaceuticals Cancer Pain Market Share (2018-2020)
Reason to Buy
- Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
- Highlights key business priorities in order to assist companies to realign their business strategies
- The segment that is expected to dominate the Pharma & Healthcare Market
- Regions that are expected to witness the fastest growth during the forecast period
- Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets